By Angela McDaniels
Seattle, Jan. 17 - OrthoHelix Surgical Designs Inc. said it has received several million dollars in new venture funding. The round was led by Mutual Capital Partners of Cleveland.
Proceeds will be used to accelerate the marketing of product lines approved by the Food and Drug Administration, to complete development of additional products and to support business growth.
"We are very impressed by the quality of the products, the targeted sales and marketing approach and the caliber of OrthoHelix's management and clinical teams," Bill Trainor, managing director of Mutual Capital, said in a company news release.
"Our firm focuses investments in companies that are ready for rapid sales growth, and that's precisely where OrthoHelix is right now."
OrthoHelix is an early stage medical device company based in Akron, Ohio, that develops instruments and implants for use in foot, ankle and hand reconstruction surgery.
| Issuer: | OrthoHelix Surgical Designs Inc.
|
| Issue: | Series A financing
|
| Investor: | Mutual Capital Partners (lead)
|
| Announcement date: | Jan. 17
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
